Multivessel disease in patient with acute myocardial infarction: current treatment strategies and future perspectives

Abstract

Patients who present with acute myocardial infarction (AMI) often suffer from coronary multivessel disease (MVD). This condition is associated with an increased mortality rate; it is, therefore, important to improve clinical outcomes through appropriate treatment strategies. Over the past decades, extensive research in AMI and MVD patients has consistently shown that complete revascularization is superior to treatment of the only culprit lesion. Another controversial issue concerns the most appropriate timing for percutaneous coronary intervention in non-culprit lesions. Fractional flow reserve (FFR) is considered the best method for identifying ischemic coronary lesions in the context of acute coronary syndromes, but the detection of vulnerable plaques in non-culprit vessels could further improve clinical outcomes. Intravascular imaging goes beyond physiology and it is potentially useful to recognize patients who are vulnerable, despite negative FFR. Therefore, we analyzed the most relevant studies that have investigated the relationship between physiological indexes and plaque vulnerability. However, ongoing trials aim to clarify how coronary physiology can be combined with the benefits of intracoronary imaging.

Keywords

Multivessel disease / acute myocardial infarction / fractional flow reserve / intravascular imaging

References

[1] Rigattieri S,Silvestri P.Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.J Interv Cardiol2008;21:1-7

[2] Wald DS,Wald NJ.Randomized trial of preventive angioplasty in myocardial infarction.N Engl J Med2013;369:1115-23

[3] Gershlick AH,Kelly DJ.Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.J Am Coll Cardiol2015;65:963-72

[4] Engstrøm T,Helqvist S.Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3 - PRIMULTI): an open-label, randomised controlled trial.Lancet2015;386:665-71

[5] Musto C,Rigattieri S.Instantaneous wave-free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST-segment elevation myocardial infarction: the WAVE study.Am Heart J2017;193:63-9

[6] Mehta SR,Storey RF.Complete revascularization with multivessel PCI for myocardial infarction.N Engl J Med2019;381:1411-21

[7] Mehta SR,Wood DA.Complete revascularization vs culprit lesion-only percutaneous coronary intervention for angina-related quality of life in patients with ST-segment elevation myocardial infarction: results from the COMPLETE randomized clinical trial.JAMA Cardiol2022;7:1091-9

[8] Pinilla-Echeverri N,Wang J.Nonculprit lesion plaque morphology in patients with ST-segment-elevation myocardial infarction: results from the COMPLETE trial optical coherence tomography substudys.Circ Cardiovasc Interv2020;13:e008768

[9] Stone GW,Lansky AJ.A prospective natural-history study of coronary atherosclerosis.N Engl J Med2011;364:226-35

[10] Prati F,Gatto L.Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study.Eur Heart J2020;41:383-91

[11] Roleder-Dylewska M,Hommels TM.Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial.Eur Heart J Cardiovasc Imaging2023;24:687-93

[12] Byrne RA,Coughlan JJ.2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC).Eur Heart J2023;44:3720-826

[13] Diletti R,Bennett J.Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.Lancet2023;401:1172-82

[14] Smits PC,Neumann FJ.Fractional flow reserve-guided multivessel angioplasty in myocardial infarction.N Engl J Med2017;376:1234-44

[15] Biscaglia S,Escaned J.Complete or culprit-only PCI in older patients with myocardial infarction.N Engl J Med2023;389:889-98

[16] Pavasini R,Barbato E.Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.Eur Heart J2020;41:4103-10

[17] Damluji AA,Wang TY.Management of acute coronary syndrome in the older adult population: a scientific statement from the American heart association.Circulation2023;147:e32-62 PMCID:PMC10312228

[18] Rioufol G,Roubille F.Fractional flow reserve to guide treatment of patients with multivessel coronary artery disease.J Am Coll Cardiol2021;78:1875-85

[19] Puymirat E,Simon T.Multivessel PCI guided by FFR or angiography for myocardial infarction.N Engl J Med2021;385:297-308

[20] Lee SH,Shin D.QFR assessment and prognosis after nonculprit PCI in patients with acute myocardial infarction.JACC Cardiovasc Interv2023;16:2365-79

[21] Lee JM,Park KH.Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.Eur Heart J2023;44:473-84

[22] Tommasino A,Barbato E.A novel quantitative flow ratio in coronary bifurcations: a simpler way to a real-time functional provisional stenting strategy.AsiaIntervention2023;9:99-100 PMCID:PMC10507605

[23] Usui E,Kanaji Y.Optical coherence tomography-defined plaque vulnerability in relation to functional stenosis severity and microvascular dysfunction.JACC Cardiovasc Interv2018;11:2058-68

[24] Hoshino M,Sugiyama T,Yonetsu T.Prevalence of OCT-defined high-risk plaque in relation to physiological characteristics by fractional flow reserve and coronary flow reserve.Rev Esp Cardiol2020;73:331-2

[25] Yang S.Coronary physiology-based approaches for plaque vulnerability: implications for risk prediction and treatment strategies.Korean Circ J2023;53:581-93 PMCID:PMC10475684

[26] Yang S,Narula J.Interactions between morphological plaque characteristics and coronary physiology: from pathophysiological basis to clinical implications.JACC Cardiovasc Imaging2022;15:1139-51

[27] Driessen RS,Raijmakers PG.Effect of plaque burden and morphology on myocardial blood flow and fractional flow reserve.J Am Coll Cardiol2018;71:499-509

[28] Yang S,Hoshino M.CT angiographic and plaque predictors of functionally significant coronary disease and outcome using machine learning.JACC Cardiovasc Imaging2021;14:629-41

[29] Koo BK,Kang J.Fractional flow reserve or intravascular ultrasonography to guide PCI.N Engl J Med2022;387:779-89

[30] Lee JM,Koo BK.Prognostic implications of plaque characteristics and stenosis severity in patients with coronary artery disease.J Am Coll Cardiol2019;73:2413-24

[31] Kedhi E,Maehara A.Impact of TCFA on unanticipated ischemic events in medically treated diabetes mellitus: insights from the PROSPECT study.JACC Cardiovasc Imaging2017;10:451-8

[32] Erlinge D,Ben-Yehuda O.Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.Lancet2021;397:985-95

[33] Stone GW,Ali ZA.Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque.J Am Coll Cardiol2020;76:2289-301

[34] Mol JQ,Belkacemi A.Fractional flow reserve-negative high-risk plaques and clinical outcomes after myocardial infarction.JAMA Cardiol2023;8:1013-21 PMCID:PMC10500430

[35] Thiele H,Sandri M.PCI strategies in patients with acute myocardial infarction and cardiogenic shock.N Engl J Med2017;377:2419-32

[36] Jentzer JC,Bhatt DL.Mechanical circulatory support devices in acute myocardial infarction-cardiogenic shock: current studies and future directions.JSCAI2023;2:100586

[37] Ali ZA,Maehara A.Optical coherence tomography-guided versus angiography-guided PCI.N Engl J Med2023;389:1466-76

[38] Holm NR,Neghabat O.OCT or angiography guidance for PCI in complex bifurcation lesions.N Engl J Med2023;389:1477-87

[39] Elbadawi A,Ghoweba M,Kayani W.Contemporary use of coronary physiology in cardiology.Cardiol Ther2023;12:589-614 PMCID:PMC10703757

[40] Vergallo R,Kakuta T.Optical Coherence tomography measures predicting fractional flow reserve: the OMEF study.JSCAI2024;3:101288

[41] Ahn JM,Lee PH.Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: rationale and design of the randomized, controlled PREVENT trial.Am Heart J2023;264:83-96